Viewing Study NCT00038220


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:17 AM
Study NCT ID: NCT00038220
Status: COMPLETED
Last Update Posted: 2006-07-27
First Post: 2002-05-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
Sponsor: Abbott
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module